Evidence map›Paper›PMID 34023900›Full record

ReviewNucleic acids research2021

A comprehensive review of m6A/m6Am RNA methyltransferase structures.

Stephanie Oerum, Vincent Meynier, Marjorie Catala, Carine Tisné

Open access · goldAbstract readReview
In one paragraph

Review in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 341 papers.

0numbers the graph read from it
0cells of the map it votes in
341citing papers in PubMed
28.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

341 citing papers in PubMed, 516 citations in OpenAlex.

  1. FTO-mediated mRNA biology · 2026
    Article
  2. mApplied biochemistry and biotechnology · 2026
    Article
  3. Article
  4. Article
  5. RNA mActa pharmacologica Sinica · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. METTL4 enhances GLI1 translation through mJournal of advanced research · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. METTL14-Mediated lncRNA MSTRG.292666.16 mInternational journal of molecular sciences · 2026
    Article
  14. Review
  15. Maternal methionine supplementation regulates skeletal muscle development through NAnimal nutrition (Zhongguo xu mu shou yi xue hui) · 2026
    Article
  16. Article
  17. NPoultry science · 2026
    Review
  18. Article
  19. Article
  20. Emerging roles of mJournal of assisted reproduction and genetics · 2026
    Review

281 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Stephanie OerumExpression Génétique Microbienne, UMR 8261, CNRS, Université de Paris, Institut de Biologie Physico-Chimique (IBPC), 75005 Paris, France.ORCID 0000-0001-9525-7295
Vincent MeynierExpression Génétique Microbienne, UMR 8261, CNRS, Université de Paris, Institut de Biologie Physico-Chimique (IBPC), 75005 Paris, France.
Marjorie CatalaExpression Génétique Microbienne, UMR 8261, CNRS, Université de Paris, Institut de Biologie Physico-Chimique (IBPC), 75005 Paris, France.
Carine TisnéExpression Génétique Microbienne, UMR 8261, CNRS, Université de Paris, Institut de Biologie Physico-Chimique (IBPC), 75005 Paris, France.ORCID 0000-0001-5534-4650
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene expression is regulated at many levels including co- or post-transcriptionally, where chemical modifications are added to RNA on riboses and bases. Expression control via RNA modifications has been termed 'epitranscriptomics' to keep with the related 'epigenomics' for DNA modification. One such RNA modification is the N6-methylation found on adenosine (m6A) and 2'-O-methyladenosine (m6Am) in most types of RNA. The N6-methylation can affect the fold, stability, degradation and cellular interaction(s) of the modified RNA, implicating it in processes such as splicing, translation, export and decay. The multiple roles played by this modification explains why m6A misregulation is connected to multiple human cancers. The m6A/m6Am writer enzymes are RNA methyltransferases (MTases). Structures are available for functionally characterized m6A RNA MTases from human (m6A mRNA, m6A snRNA, m6A rRNA and m6Am mRNA MTases), zebrafish (m6Am mRNA MTase) and bacteria (m6A rRNA MTase). For each of these MTases, we describe their overall domain organization, the active site architecture and the substrate binding. We identify areas that remain to be investigated, propose yet unexplored routes for structural characterization of MTase:substrate complexes, and highlight common structural elements that should be described for future m6A/m6Am RNA MTase structures.

Indexed as

AdenosineAnimalsBacteriaHumansMethyltransferasesZebrafish Proteins2'-O-methyladenosineAdenosineMethyltransferasesMETTL14 protein, humanMETTL16 protein, humanMETTL3 protein, humanMETTL5 protein, humanN-methyladenosineTRMT112 protein, humanZCCHC4 protein, humanZebrafish Proteins

Identifiers

PMID34023900
PMCPMC8287941
OpenAlexW3165331125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.